What are Circulating tumor
cells?
 These are cells which shed from a
cancerous tumor, enter the circulatory
system through the blood and affects
other organs, leading to death of that
organism.
 The first CTCs were observed in the
year 1869 by Thomas Ashworth. He
demonstrated its critical role in the
spread of metastatic
carcinoma. Ashworth, T. R (1869).
2VIII SEMESTER TECHNICAL SEMINAR4/28/2016
CTC under Microscope
(fluorescent labeled)
3VIII SEMESTER TECHNICAL SEMINAR4/28/2016
 Circulating tumor cells are found in
frequencies on the order of 1-10 CTC per ml
of whole blood in patients with metastatic
disease.
 They posses the characteristics which reflect
the heterogeneity of cancer.
 Hence there isolation and identification is quite
challenging and not so easily detected.
Yu M., Haber D. A., et al. (2012).
4VIII SEMESTER TECHNICAL SEMINAR4/28/2016
DETECTION & ISOLATION
METHODS
5VIII SEMESTER TECHNICAL SEMINAR4/28/2016
CELL SEARCH METHOD-(epithelial
cell adhesion molecule) EpCAM
method
Yu M., Haber D. A., et al. (2012).
6VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Gold based nano-particle
adherence method
7VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Mosaic CTC assay method
8VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Di-electrophoresis separation
9VIII SEMESTER TECHNICAL SEMINAR4/28/2016
ISOFLUX SYSTEM
10VIII SEMESTER TECHNICAL SEMINAR4/28/2016
CTC-CHIP
An Exciting New Tool to Detect Circulating
Tumor Cells in Lung Cancer and Prostate
Cancer Patients
(M. Toner,J. Kaiser)
11VIII SEMESTER TECHNICAL SEMINAR4/28/2016
 It is a Silicon Chip of the size of standard microscopic slide.
 It has an array of 78,000µm-sized posts and they are etched
in a specific geometric pattern.
 The chip is “functionalized” with Epithelial cell adhesion
molecule (EpCAM).
 It was introduced by Dr. Mehmet Toner in the year 2007, at
Massachusetts General Hospital. (M. Toner,J. Kaiser)
12VIII SEMESTER TECHNICAL SEMINAR4/28/2016
13VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Fluorescent Staining of different
antibodies present within the metastatic
cells
14VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Structure of CTC lung Cancer
under Microscope
15VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Structure of CTC Breast Cancer
under Microscope
16VIII SEMESTER TECHNICAL SEMINAR4/28/2016
Structure of CTC Colon Cancer
under Microscope
17VIII SEMESTER TECHNICAL SEMINAR4/28/2016
 Scientists believe that Micro Fluidics will play a
significant role in promoting the study of CTCs
and advancing the race toward achieving clinical
relevance.
 Some of the Microfluidics system has already
gained importance in the world of clinical trials.
 Microfluidics has facilitated the development of
many innovative and flexible research systems
that can capture CTCs at increasingly higher
yields and facilitate all manners of downstream
characterization.
 Recent research is made to make CTCs as
therapeutic drug targets and biomarkers. (Butler
JE, Ni L)
Future Prospects…
18VIII SEMESTER TECHNICAL SEMINAR4/28/2016
CTCs are the messenger and message of
metastasis
19VIII SEMESTER TECHNICAL SEMINAR4/28/2016
BIBLIOGRAPHY
 Butler JE, Ni L, Nessler R, Joshi KS, Suter M, Rosenberg B, Chang J,Brown
WR, Cantarero LA: The physical and functional behavior of capture
antibodies adsorbed on polystyrene. J Immunol Methods 1992,150:77e90.
 M. Toner. (2013, January 14). Keynote Speaker. SLAS Conference: Miami,
Florida.
 J. Kaiser. (2010). “Cancer's Circulation Problem.” Science Journals. (Online
article). http://www.sciencemag.org/content/327/5969/1072.full.
 Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumor cells: a novel
prognostic factor for newly diagnosed metastatic breast cancer,J Clin Oncol
2005;23:1420 –1430.
 Ashworth, T. R (1869). "A case of cancer in which cells similar to those in
the tumors were seen in the blood after death". Australian Medical
Journal 14: 146–7.
 Yu M., Haber D. A., et al. (2012). "RNA sequencing of pancreatic circulating
tumor cells implicates WNT signaling in metastasis". Nature 487 (7408):
510–3.
 Butler JE, Ni L, Nessler R, Joshi KS, Suter M, Rosenberg B, Chang J,Brown
WR, Cantarero LA: The physical and functional behavior of capture
antibodies adsorbed on polystyrene. J Immunol Methods 1992,150:77e90
20VIII SEMESTER TECHNICAL SEMINAR4/28/2016
21
VIII SEMESTER TECHNICAL SEMINAR4/28/2016

Circulating tumor cells

  • 2.
    What are Circulatingtumor cells?  These are cells which shed from a cancerous tumor, enter the circulatory system through the blood and affects other organs, leading to death of that organism.  The first CTCs were observed in the year 1869 by Thomas Ashworth. He demonstrated its critical role in the spread of metastatic carcinoma. Ashworth, T. R (1869). 2VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 3.
    CTC under Microscope (fluorescentlabeled) 3VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 4.
     Circulating tumorcells are found in frequencies on the order of 1-10 CTC per ml of whole blood in patients with metastatic disease.  They posses the characteristics which reflect the heterogeneity of cancer.  Hence there isolation and identification is quite challenging and not so easily detected. Yu M., Haber D. A., et al. (2012). 4VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 5.
    DETECTION & ISOLATION METHODS 5VIIISEMESTER TECHNICAL SEMINAR4/28/2016
  • 6.
    CELL SEARCH METHOD-(epithelial celladhesion molecule) EpCAM method Yu M., Haber D. A., et al. (2012). 6VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 7.
    Gold based nano-particle adherencemethod 7VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 8.
    Mosaic CTC assaymethod 8VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 9.
  • 10.
    ISOFLUX SYSTEM 10VIII SEMESTERTECHNICAL SEMINAR4/28/2016
  • 11.
    CTC-CHIP An Exciting NewTool to Detect Circulating Tumor Cells in Lung Cancer and Prostate Cancer Patients (M. Toner,J. Kaiser) 11VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 12.
     It isa Silicon Chip of the size of standard microscopic slide.  It has an array of 78,000µm-sized posts and they are etched in a specific geometric pattern.  The chip is “functionalized” with Epithelial cell adhesion molecule (EpCAM).  It was introduced by Dr. Mehmet Toner in the year 2007, at Massachusetts General Hospital. (M. Toner,J. Kaiser) 12VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 13.
    13VIII SEMESTER TECHNICALSEMINAR4/28/2016
  • 14.
    Fluorescent Staining ofdifferent antibodies present within the metastatic cells 14VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 15.
    Structure of CTClung Cancer under Microscope 15VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 16.
    Structure of CTCBreast Cancer under Microscope 16VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 17.
    Structure of CTCColon Cancer under Microscope 17VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 18.
     Scientists believethat Micro Fluidics will play a significant role in promoting the study of CTCs and advancing the race toward achieving clinical relevance.  Some of the Microfluidics system has already gained importance in the world of clinical trials.  Microfluidics has facilitated the development of many innovative and flexible research systems that can capture CTCs at increasingly higher yields and facilitate all manners of downstream characterization.  Recent research is made to make CTCs as therapeutic drug targets and biomarkers. (Butler JE, Ni L) Future Prospects… 18VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 19.
    CTCs are themessenger and message of metastasis 19VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 20.
    BIBLIOGRAPHY  Butler JE,Ni L, Nessler R, Joshi KS, Suter M, Rosenberg B, Chang J,Brown WR, Cantarero LA: The physical and functional behavior of capture antibodies adsorbed on polystyrene. J Immunol Methods 1992,150:77e90.  M. Toner. (2013, January 14). Keynote Speaker. SLAS Conference: Miami, Florida.  J. Kaiser. (2010). “Cancer's Circulation Problem.” Science Journals. (Online article). http://www.sciencemag.org/content/327/5969/1072.full.  Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer,J Clin Oncol 2005;23:1420 –1430.  Ashworth, T. R (1869). "A case of cancer in which cells similar to those in the tumors were seen in the blood after death". Australian Medical Journal 14: 146–7.  Yu M., Haber D. A., et al. (2012). "RNA sequencing of pancreatic circulating tumor cells implicates WNT signaling in metastasis". Nature 487 (7408): 510–3.  Butler JE, Ni L, Nessler R, Joshi KS, Suter M, Rosenberg B, Chang J,Brown WR, Cantarero LA: The physical and functional behavior of capture antibodies adsorbed on polystyrene. J Immunol Methods 1992,150:77e90 20VIII SEMESTER TECHNICAL SEMINAR4/28/2016
  • 21.